Select a Region
North America

Your hub for company news and information

EVERSANA
Posted on 9月 19, 20239/19/23

Sy Pretorius, EVERSANA Chief Operating Officer, Named to Prestigious PharmaVoice 100 List for 2023

Read More
EVERSANA
Posted on 9月 18, 20239/18/23

EVERSANA Unveils ACTICS eAccess, New Technology-Enabled eBV and ePA Patient Support Platform to Improve Patient Access and Accelerate Speed to Therapy

EVERSANA
Posted on 9月 6, 20239/6/23

EVERSANA Names Ryan Sparks Chief Information Officer  

EVERSANA
Posted on 8月 30, 20238/30/23

EVERSANA Unveils EVERSANA ORCHESTRATE, Life Science Industry’s First End-to-End Omnichannel Solution Driving Brand Connectivity and Activating Commercialization Services

EVERSANA
Posted on 7月 25, 20237/25/23

Evoke Pharma and EVERSANA Announce Abstract Selection for Plenary Oral Presentation at The American College of Gastroenterology (ACG) 2023 Annual Meeting

EVERSANA
Posted on 7月 24, 20237/24/23

EVERSANA & Amazon Web Services to “Pharmatize” Artificial Intelligence across the Life Sciences Industry

EVERSANA
Posted on 6月 26, 20236/26/23

EVERSANA INTOUCH Wins Gold at Cannes Lions International Festival of Creativity

EVERSANA
Posted on 6月 5, 20236/5/23

EVERSANA INTOUCH Wins Five Clio Awards

EVERSANA
Posted on 6月 1, 20236/1/23

EVERSANA Forms Strategic Alliance with China Resource Pharmaceutical Commercial Group to Bring New Novel Treatments to Patients Globally

Posted on 5月 25, 20235/25/23

Renalytix Selects EVERSANA to Expand Commercialization of KidneyIntelX for Early-Stage Kidney Disease Prognosis Detection in Patients with Type 2 Diabetes

EVERSANA
Posted on 5月 22, 20235/22/23

Yaral Pharma Partners with EVERSANA to Support the Commercialization of its Expanded Generics Portfolio